Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Inflammatory Bowel Diseases

Free Subscription Articles published in Z Gastroenterol Retrieve available abstracts of 27 articles: HTML format

Single Articles

April 2026
1. DIGNASS A, Teich N, Kaiser S, Sunwoldt J, et al
   Therapy Persistence and Dose Escalation of Advanced Treatments in First and Second Line of Ulcerative Colitis and Crohn's Disease - A Retrospective Cohort Analysis of Healthcare Claims Data.
   Z Gastroenterol. 2026 Apr 21. doi: 10.1055/a-2836-5222.
   PubMed     Abstract available
   
   
   March 2026
2. STEIN J, Schroeder O, Tessmer L, Muller E, et al
   [Obesity meets Inflammatory Bowel Disease - a Double Whammy? A narrative Review].
   Z Gastroenterol. 2026;64:283-299.
   PubMed     Abstract available
   
   
   February 2026
3. ALEXANIDOU E, Horning A, de Laffolie J, Schmidt-Choudhury A, et al
   [Crohn's Disease Exclusion Diet (CDED) and partial enteral nutrition (PEN) for remission induction in children and adolescents with Crohn's Disease - Updated statement from the CEDATA and Nutrition/Dietetics/Nutritional Medicine Working Groups of the
   Z Gastroenterol. 2026;64:184-198.
   PubMed     Abstract available
   
   
   
4. ALEXANIDOU E, Horning A, de Laffolie J, Schmidt-Choudhury A, et al
   [Correction: Crohn's Disease Exclusion Diet (CDED) and partial enteral nutrition (PEN) for remission induction in children and adolescents with Crohn's Disease - Updated statement from the CEDATA and Nutrition/Dietetics/Nutritional Medicine Working Gr
   Z Gastroenterol. 2026;64:e85.
   PubMed    
   
   
   January 2026
5. POKRYSZKA J, Primas C, Stadlmann M, Gerold N, et al
   Post-induction serum vedolizumab levels are not associated with better maintenance outcomes in patients with Crohn's disease.
   Z Gastroenterol. 2026 Jan 12. doi: 10.1055/a-2744-5136.
   PubMed     Abstract available
   
   
   
6. ZECHER BF, Schramm C
   [Immunopathogenesis and therapy of primary sclerosing cholangitis].
   Z Gastroenterol. 2026;64:56-66.
   PubMed     Abstract available
   
   
   October 2025
7. SCHNOY E, Dignass A, Gaskins M, Kucharzik T, et al
   Correction: From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.
   Z Gastroenterol. 2025;63:e668-e669.
   PubMed    
   
   
   June 2025
8. SCHNOY E, Dignass A, Gaskins M, Kucharzik T, et al
   From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.
   Z Gastroenterol. 2025 Jun 16. doi: 10.1055/a-2596-8934.
   PubMed     Abstract available
   
   
   May 2025
9. PUESCHEL L, Hupa-Breier K, Wedemeyer H, Lenzen H, et al
   Food-related Quality of Life in patients with Inflammatory Bowel Disease: Translation and Validation of the German version of FR-QoL-29.
   Z Gastroenterol. 2025;63:477-485.
   PubMed     Abstract available
   
   
   March 2025
10. DABRITZ J, Classen M, Krohn K, Krahl A, et al
    [Position paper of the Society for Paediatric Gastroenterology and Nutrition (GPGE) on the off-label use of biologics and signal inhibitors in children and adolescents with IBD that have already been approved for adults].
    Z Gastroenterol. 2025;63:255-268.
    PubMed     Abstract available
    
    
    
11. REINER J, Becker AS, Huth A, Lamprecht G, et al
    Mirikizumab for the treatment of chronic antibiotic-refractory pouchitis.
    Z Gastroenterol. 2025;63:269-272.
    PubMed     Abstract available
    
    
    November 2024
12. WEI X, Tang D
    Effect of Bacteroides on Crohn's disease.
    Z Gastroenterol. 2024 Nov 25. doi: 10.1055/a-2435-2659.
    PubMed     Abstract available
    
    
    
13. DIETMAIER L, Summa S, Ronicke M, Erfurt-Berge C, et al
    Peristomal skin lesions - identifying patients at risk.
    Z Gastroenterol. 2024;62:1924-1930.
    PubMed     Abstract available
    
    
    August 2024
14. STURM A, Atreya R, Bettenworth D, Bokemeyer B, et al
    [Not Available].
    Z Gastroenterol. 2024;62:1229-1318.
    PubMed    
    
    
    
15. LORENZ P, Stallmach A, Sturm A, Lynen Jansen P, et al
    [Not Available].
    Z Gastroenterol. 2024;62:e531-e536.
    PubMed    
    
    
    May 2024
16. KUCHARZIK T, Dignass A, Atreya R, Bokemeyer B, et al
    [Not Available].
    Z Gastroenterol. 2024;62:769-858.
    PubMed    
    
    
    
17. LORENZ P, Dignass A, Kucharzik T, Jansen PL, et al
    [Not Available].
    Z Gastroenterol. 2024;62:e470-e476.
    PubMed    
    
    
    April 2024
18. STRATMANN K, Hentschel V, Zeuzem S, Blumenstein I, et al
    [Iron supplementation in patients with chronic inflammatory bowel disease: recommendations for a practical approach].
    Z Gastroenterol. 2024 Apr 24. doi: 10.1055/a-2274-1610.
    PubMed     Abstract available
    
    
    
19. SCHMIDT C, Stallmach A, Sturm A, Bachmann O, et al
    [Update: Addendum to S3-Guidelines Crohn disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease with regard to COVID-19 (version 2.0)].
    Z Gastroenterol. 2024;62:517-534.
    PubMed    
    
    
    February 2024
20. KOLLECKER T, Nistal M, Waltz V, Ehard F, et al
    [Takayasu arteritis after COVID-19 infection in a 26-year-old female patient with Crohn's disease].
    Z Gastroenterol. 2024 Feb 28. doi: 10.1055/a-2187-9295.
    PubMed     Abstract available
    
    
    
21. HAFNER S, Seufferlein T, Kleger A, Muller M, et al
    Symptoms and Management of Aseptic Liver Abscesses.
    Z Gastroenterol. 2024;62:208-217.
    PubMed     Abstract available
    
    
    November 2023
22. REIDER S, Novacek G, Haas T, Grochenig HP, et al
    [Use of subcutaneous Vedolizumab: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (OGGH)].
    Z Gastroenterol. 2023;61:1518-1525.
    PubMed     Abstract available
    
    
    October 2023
23. MOLL-VON DER WETTERN M, Heinlein W, Rathmayer M, Koller L, et al
    [A critical DRG-evaluation of cases with inflammatory bowel disease].
    Z Gastroenterol. 2023 Oct 12. doi: 10.1055/a-2075-2533.
    PubMed     Abstract available
    
    
    September 2023
24. DEMMER S, Kleindienst N, Hjortswang H, Thomann P, et al
    Validation of the German version of the Short Health Scale - a brief, valid and reliable instrument to assess health-related quality of life in German-speaking patients with inflammatory bowel diseases.
    Z Gastroenterol. 2023;61:1207-1213.
    PubMed     Abstract available
    
    
    August 2023
25. KUCHARZIK T, Dignass A, Atreya R, Bokemeyer B, et al
    [Not Available].
    Z Gastroenterol. 2023;61:1046-1134.
    PubMed    
    
    
    
26. KUCHARZIK T, Dignass A
    [Not Available].
    Z Gastroenterol. 2023;61:1000-1001.
    PubMed    
    
    
    
27. LORENZ P, Dignass A, Kucharzik T, Fischer N, et al
    [Not Available].
    Z Gastroenterol. 2023;61:e358-e364.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum